BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37930408)

  • 1. Nodal staging with MRI after neoadjuvant chemo-radiotherapy for locally advanced rectal cancer: a fast and reliable method.
    Crimì F; Cabrelle G; Campi C; Schillaci A; Bao QR; Pepe A; Spolverato G; Pucciarelli S; Vernuccio F; Quaia E
    Eur Radiol; 2024 May; 34(5):3205-3214. PubMed ID: 37930408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging for assessment of rectal cancer nodes after chemoradiotherapy: A single center experience.
    Barbaro B; Carafa MRP; Minordi LM; Testa P; Tatulli G; Carano D; Fiorillo C; Chiloiro G; Romano A; Valentini V; Gambacorta MA
    Radiother Oncol; 2024 Apr; 193():110124. PubMed ID: 38309586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic accuracy of 3.0T high-resolution MRI for assessment mesorectal lymph node metastases in patients with rectal cancer].
    Chen Y; Yang X; Lu B; Xiao X; Zhuang X; Yu S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jul; 21(7):786-792. PubMed ID: 30051447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of MRI in assessing tumor regression and identifying complete response in patients with locally advanced rectal cancer after neoadjuvant treatment.
    Aker M; Boone D; Chandramohan A; Sizer B; Motson R; Arulampalam T
    Abdom Radiol (NY); 2018 Dec; 43(12):3213-3219. PubMed ID: 29767284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative lateral lymph node features and impact on local recurrence after neoadjuvant chemoradiotherapy and total mesorectal excision for locally advanced rectal cancer: results from a multicentre international cohort study.
    Achilli P; Ferrari D; Calini G; Bertoglio CL; Magistro C; Origi M; Carnevali P; Alampi BD; Giusti I; Ferrari G; Calafiore E; Spinelli A; Grass F; Deslarzes P; Hahnloser D; Abdalla S; Larson DW
    Colorectal Dis; 2024 Mar; 26(3):466-475. PubMed ID: 38243617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI for nodal restaging after neoadjuvant therapy in rectal cancer with histopathologic comparison.
    Zhang Z; Chen Y; Wen Z; Wu X; Que Y; Ma Y; Wu Y; Liu Q; Fan W; Yu S
    Cancer Imaging; 2023 Jul; 23(1):67. PubMed ID: 37443085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer.
    Lambregts DM; Beets GL; Maas M; Kessels AG; Bakers FC; Cappendijk VC; Engelen SM; Lahaye MJ; de Bruïne AP; Lammering G; Leiner T; Verwoerd JL; Wildberger JE; Beets-Tan RG
    Ann Surg; 2011 Mar; 253(3):539-45. PubMed ID: 21239980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy.
    Ogura A; Konishi T; Beets GL; Cunningham C; Garcia-Aguilar J; Iversen H; Toda S; Lee IK; Lee HX; Uehara K; Lee P; Putter H; van de Velde CJH; Rutten HJT; Tuynman JB; Kusters M;
    JAMA Surg; 2019 Sep; 154(9):e192172. PubMed ID: 31268504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of high-resolution rectal magnetic resonance imaging re-staging with histopathology in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Laohawiriyakamol S; Worathanmanon S; Tubtawee T; Kanjanapradit K; Sangkhathat S; Pruphetkaew N; Chongsuvivatwong V
    Asian J Surg; 2021 Jan; 44(1):275-279. PubMed ID: 32712044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of N0 Irradiated Rectal Cancer Comparing MRI Before and After Preoperative Chemoradiotherapy.
    Pomerri F; Crimì F; Veronese N; Perin A; Lacognata C; Bergamo F; Boso C; Maretto I
    Dis Colon Rectum; 2017 Nov; 60(11):1184-1191. PubMed ID: 28991083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: An international multi-centre comparative study.
    Kroon HM; Malakorn S; Dudi-Venkata NN; Bedrikovetski S; Liu J; Kenyon-Smith T; Bednarski BK; Ogura A; van de Velde CJH; Rutten HJT; Beets GL; Thomas ML; Kusters M; Chang GJ; Sammour T
    Eur J Surg Oncol; 2021 Sep; 47(9):2441-2449. PubMed ID: 34120810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating mesorectal lymph nodes in rectal cancer before and after neoadjuvant chemoradiation using thin-section T2-weighted magnetic resonance imaging.
    Koh DM; Chau I; Tait D; Wotherspoon A; Cunningham D; Brown G
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):456-61. PubMed ID: 18164860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
    Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
    World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of neoadjuvant chemoradiotherapy combined with lateral lymph nodes dissection or not on the local recurrence of low to intermediate-stage II/III rectal cancer.
    Li C; Luan J; Ji X; Wang X; Li J; Li X; Zhou Y
    J Surg Oncol; 2024 Feb; 129(2):273-283. PubMed ID: 37811551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversy in the initial nodal staging of rectal cancer (MRI or PET/CT?).
    López Llobet E; Coronado Poggio M; Lancha Hernández C; Martín Hervás C; Travaglio Morales D; Monachello Araujo D; Rodado Marina S; Domínguez Gadea L
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(3):500004. PubMed ID: 38527730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and validation of nomograms for predicting mesorectal lymph node staging and restaging.
    Zhuang Z; Ma X; Zhang Y; Yang X; Wei M; Deng X; Wang Z
    Int J Colorectal Dis; 2022 Sep; 37(9):2069-2083. PubMed ID: 36028723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of Patients With Rectal Cancer for Preoperative Chemoradiotherapy: Are T Category and Nodal Status All That Matters?
    Pooni A; Al-Sukhni E; Milot L; Fruitman M; Victor JC; Schmocker S; Brown G; Kennedy E
    Dis Colon Rectum; 2019 Apr; 62(4):447-453. PubMed ID: 30451758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02.
    Lee JH; Jang HS; Kim JG; Lee MA; Kim DY; Kim TH; Oh JH; Park SC; Kim SY; Baek JY; Park HC; Kim HC; Nam TK; Chie EK; Jung JH; Oh ST
    Radiother Oncol; 2014 Oct; 113(1):18-23. PubMed ID: 25245559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes?
    Lahaye MJ; Beets GL; Engelen SM; Kessels AG; de Bruïne AP; Kwee HW; van Engelshoven JM; van de Velde CJ; Beets-Tan RG
    Radiology; 2009 Jul; 252(1):81-91. PubMed ID: 19403848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.